I. Murray

发表

Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics

V. Romanov, S. Khan, Jason Gandhi, 2019, Reviews in the neurosciences.

Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.

J. Trojanowski, P. Axelsen, B. Giasson, 2003, Biochemistry.

Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.

P. Axelsen, H. Komatsu, I. Murray, 2011, Physiology.

Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer’s Disease (AD): A Meta-Analysis of CSF Markers

D. B. Moore, G. Perry, J. Friedrich, 2018, Current Alzheimer research.

Role of α-Synuclein Carboxy-Terminus on Fibril Formation in Vitro†

P. Axelsen, B. Giasson, H. Ischiropoulos, 2003 .

Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.

Karen Duong, J. Tingling, I. Murray, 2010, Biochemistry.

Early Synergy between Aβ42 and Oxidatively Damaged Membranes in Promoting Amyloid Fibril Formation by Aβ40*

P. Axelsen, V. Koppaka, I. Murray, 2003, Journal of Biological Chemistry.

Histology, Kidney and Glomerulus

I. Murray, M. Paolini, 2020 .

A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly*

J Q Trojanowski, J. Trojanowski, V. Lee, 2001, The Journal of Biological Chemistry.

Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid β Proteins*

Gang Xiao, K. Uryu, P. Axelsen, 2007, Journal of Biological Chemistry.

Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product.

P. Axelsen, H. Komatsu, I. Murray, 2008, Journal of molecular biology.

Amyloid-β metabolite sensing: biochemical linking of glycation modification and misfolding.

Xiongwei Zhu, I. Murray, Janelle N. Fawver, 2012, Journal of Alzheimer's disease : JAD.

Promotion of oxidative lipid membrane damage by amyloid beta proteins.

P. Axelsen, I. Murray, M. Sindoni, 2005, Biochemistry.

Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression.

J. Trojanowski, V. Lee, Yuxin Fan, 2006, Human molecular genetics.

TNFα-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish s-adenosylhomocysteine hydrolase

M. Pack, I. Blair, I. Murray, 2009, Development.

Mass spectrometric analysis demonstrates that BODIPY 581/591 C11 overestimates and inhibits oxidative lipid damage.

P. Axelsen, I. Murray, M. MacDonald, 2007, Free radical biology & medicine.

A mechanistic link between oxidative stress and membrane mediated amyloidogenesis revealed by infrared spectroscopy.

P. Axelsen, H. Komatsu, I. Murray, 2007, Biochimica et biophysica acta.

Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

J. Trojanowski, V. Lee, B. Giasson, 2000, Science.

Adenosine triphosphate (ATP) reduces amyloid-β protein misfolding in vitro.

I. Murray, Orkid Coskuner, 2014, Journal of Alzheimer's disease : JAD.

Amyloid Plaque-Associated Oxidative Degradation of Uniformly Radiolabeled Arachidonic Acid.

P. Axelsen, I. Murray, Qiwei Liu, 2016, ACS chemical neuroscience.

Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.

D. Zimmer, L. Holcomb, I. Murray, 2010, Journal of Alzheimer's disease : JAD.

Promotion of Oxidative Lipid Membrane Damage by Amyloid β Proteins

P. Axelsen, I. Murray, M. Sindoni, 2005 .

Small molecules and Alzheimer's disease: misfolding, metabolism and imaging.

Karen Duong, Chongzhao Ran, I. Murray, 2015, Current Alzheimer research.

Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?

B. Bass, Kamolika Roy, I. Murray, 2015, Neural regeneration research.

Vascular and metabolic dysfunction in Alzheimer's disease: a review

F. Sohrabji, J. Lawler, Farida Sohrabji, 2011, Experimental biology and medicine.

Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.

J. Jhamandas, K. Dineley, I. Murray, 2014, Current Alzheimer research.

Beta-synuclein gene alterations in dementia with Lewy bodies.

J. Trojanowski, V. Lee, A. Kakita, 2004, Neurology.

Synphilin in normal human brains and in synucleinopathies: studies with new antibodies

J. Trojanowski, V. Lee, I. Murray, 2003, Acta Neuropathologica.

Synucleinopathies: a pathological and molecular review

J. Trojanowski, V. Lee, I. Murray, 2001, Clinical Neuroscience Research.

Age-dependent synuclein pathology following traumatic brain injury in mice

J. Trojanowski, V. Lee, K. Uryu, 2003, Experimental Neurology.

Potential role of α‐synuclein in neurodegeneration: studies in a rat animal model

G. Taglialatela, G. Stoica, Nicole L. Bjorklund, 2012, Journal of neurochemistry.

-synuclein modulates -synuclein neurotoxicity by reducing -synuclein protein expression

John Q. Trojanowski, J. Trojanowski, V. Lee, 2006 .

β-Synuclein gene alterations in dementia with Lewy bodies

J. Trojanowski, V. Lee, A. Kakita, 2004, Neurology.

Amyloids as Sensors and Protectors (ASAP) hypothesis.

I. Murray, Janelle N. Fawver, M. Emery, 2012, Journal of Alzheimer's disease : JAD.

Amyloid β peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system

A. Touhami, L. Colom, M. Perez-Córdova, 2013, Neurobiology of Aging.

Probing and trapping a sensitive conformation: amyloid-β fibrils, oligomers, and dimers.

Xiongwei Zhu, L. Colom, Karen Duong, 2012, Journal of Alzheimer's disease : JAD.

Ruthenium red colorimetric and birefringent staining of amyloid-β aggregates in vitro and in Tg2576 mice.

K. Dineley, A. Martí, N. P. Cook, 2013, ACS chemical neuroscience.

Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics

V. Romanov, S. Khan, Jason Gandhi, 2019, Reviews in the neurosciences.

Physiology, Pulmonary Vasoconstriction

Stephen J Bordes, I. Murray, Sandeep Sharma, 2020 .